1700016D02Rik Activators
"1700016D02Rik" is a nomenclature for a gene found in the mouse genome, used by researchers to track and study its function within the organism. This gene is part of a larger set of genes whose products and roles are not fully characterized, representing a segment of the genetic catalog that requires detailed investigation to understand. The exploration of "1700016D02Rik" begins with establishing its expression profile, which involves utilizing quantitative PCR (qPCR) to measure mRNA levels of the gene in various mouse tissues. This method can provide a precise quantification of gene expression, offering a clear picture of when and where the gene is active. Complementing qPCR, RNA sequencing is used to capture a comprehensive view of the gene's transcripts, including any alternative splicing events, across different cell types and developmental stages. The data gathered from these techniques are critical for determining the physiological contexts in which "1700016D02Rik" is expressed, which in turn gives insight into its biological functions.
Immunofluorescence or immunohistochemistry techniques are pivotal for establishing the subcellular localization of the protein, which can be indicative of its role in cellular processes. The interaction of the protein with other cellular molecules is also a key area of research. Techniques such as co-immunoprecipitation, followed by mass spectrometry, can identify the protein's interaction partners, which provides insight into the cellular pathways that the protein is involved in. Additionally, gene knockout studies, facilitated by CRISPR-Cas9 technology, enable the observation of cellular and organismal changes in the absence of the gene product, offering a direct way to assess the functional role of the gene.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. The increased levels of these cyclic nucleotides can enhance the signaling pathways that involve 1700016D02Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which is involved in numerous signaling cascades. Activation of PKC can lead to phosphorylation events that promote the functional activity of 1700016D02Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, thereby activating calcium-dependent signaling pathways. These pathways can enhance the activity of 1700016D02Rik if it is calcium-sensitive or part of calcium-regulated processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to have inhibitory effects on various protein kinases. By altering kinase activity, EGCG can shift signaling dynamics to favor pathways in which 1700016D02Rik is activated. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can change the balance of cellular signaling, potentially enhancing pathways where 1700016D02Rik is involved by reducing competitive signaling through the PI3K/AKT pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By selectively inhibiting p38 MAPK, it may enhance the activation of alternate signaling routes involving 1700016D02Rik. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720, after phosphorylation, acts as a sphingosine-1-phosphate receptor modulator. This can lead to changes in cellular signaling that enhance the activity of proteins in the pathways where 1700016D02Rik is implicated. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which can interfere with the MAPK/ERK pathway. By inhibiting this pathway, PD98059 might shift signaling towards pathways that involve the activation of 1700016D02Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore like ionomycin and functions similarly by increasing intracellular calcium and potentially enhancing signaling pathways that involve 1700016D02Rik. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Dibutyryl-cAMP is a cell-permeable cAMP analog that can activate PKA and thereby potentially enhance pathways that include 1700016D02Rik. | ||||||